Sedivetion, a Munich, Germany-based medical technology startup, raised 800K in Pre-Seed funding.
The round was led by High-Tech Gründerfonds (HTGF).
The company intends to use the funds to advance the first preclinical studies and product development.
Founded by Dr. Ute Nollert and Dr. Andreas Bröcker, Sedivention is developing a cryocatheter that ablates the gastric branches of the vagus nerve within minutes. The procedure can be performed in an outpatient setting, similar to a gastroscopy, as a one-time, minimally invasive procedure. The new procedure will also have a positive impact on obesity-related comorbidities such as diabetes and hypertension.
FinSMEs
02/12/2024